Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation

British Journal of Haematology

Volumn 106, Issue 2, 1999, Pages 545-552

  Rottenburger, Christof ^a   Kiel, Katja ^a   Bösing, Tobias ^a   Cremer, Friedrich W ^a   Moldenhauer, Gerhard ^b   Ho, Anthony D ^a   Goldschmidt, Hartmut ^a   Moos, Marion ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Anti CD20 antibody treatment; Clonotypic B cells; High dose therapy; Multiple myeloma; Residual disease

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE;

ADULT; ARTICLE; B LYMPHOCYTE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CELL CLONE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ADULT; AGED; ANTIGENS, CD19; ANTIGENS, CD20; B-LYMPHOCYTES; CLONE CELLS; DNA PRIMERS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM, RESIDUAL; SENSITIVITY AND SPECIFICITY;

EID: 0032821233     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01548.x     Document Type: Article

References (19)

1. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomized trial of autologous bone-marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
2. Barlogie, B., Jagannath, S., Desikan, K.R., Mattox, S., Vesole, D., Siegel, D., Tricot, G., Munshi, N., Fassas, A., Singhal, S., Mehta, E., Anaissie, E., Dhodapkar, S., Naucke, S., Cromer, J., Sawyer, J., Epstein, J., Spoon, D., Ayers, D., Cheson, B. & Crowley, J. (1999) Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood, 93, 55-65.
3. Barlogie, B., Jagannath, S., Vesole, D.H., Naucke, S., Cheson, B., Mattox, S., Bracy, D., Salmon, S., Jacobson, J., Crowley, J. & Tricot, G. (1997) Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood, 89, 789-793.
4. + peripheral blood cells expressing CD38, CD56 and monotypic Ig light chain. Blood, 85, 436-447.
5. Billadeau, D., Prosper, F., Verfaillie, C., Weisdorf, D. & Van Ness, B. (1997) Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement. Leukemia, 11, 1565-1570.
6. Chen, B.J. & Epstein, J. (1996) Circulating clonal lymphocytes in myeloma constitute only a minor subpopulation of B cells. Blood, 87, 1972-1976.
7. Coiflier, B., Haioun, C., Ketterer, N., Engert, A., Tilly, H., Ma, D., Johnson, P., Lister, A., Feuring-Buske, M., Radford, J.A., Capdeville, R., Diehl, V. & Reyes, F. (1998) Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood, 92, 1927-1932.
8. Cremer, F.W., Kiel, K., Wallmeier, M., Goldschmidt, H. & Moos, M. (1997) A quantitative PCR assay for the dectection of low amounts of malignant cells in multiple myeloma. Annals of Oncology, 8, 633-636.
9. Goldschmidt, H., Hegenbart, U., Wallmeier, M., Hohaus, S., Engenhart, R., Wannenmacher, M. & Haas, R. (1997) High dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma. Annals of Oncology, 8, 243-246.
10. + monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood, 78, 711-719.
11. Kay, N.E., Leong, T., Kyle, R.A., Greipp, P., Billadeau, D., Van Ness, B., Bone, N. & Oken, M.M. (1997) Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial. Blood, 90, 340-345.
12. Kiel, K., Cremer, F.W., Rottenburger, C., Kallmeyer, C., Ehrbrecht, E., Atzberger, A., Hegenbart, U., Goldschmidt, H. & Moos, M. (1999) Analysis of circulating tumor cells in patients with multiple myeloma in the course of high-dose therapy with peripheral blood stem cell transplantation. Bone Marrow Transplantation, 23, 1019-1027.
13. Maloney, D.G., Donavan, K. & Hamblin, T.J. (1999) Antibody therapy for treatment of multiple myeloma. Seminars in Hematology, 36, 30-33.
14. Maloney, D.G., Grillo-Lopez, A.J., White, C.A., Bodkin, D., Schilder, R.J., Neidhart, J.A., Janakiraman, N., Foon, K.A., Liles, T.M., Dallaire, B.K., Wey, K., Royston, I., Davis, T. & Levy, R. (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood, 90, 2188-2195.
15. Maloney, D.G., Liles, T.M., Czerwinski, D.K., Waldichuk, C., Rosenberg, J., Grillo-Lopez, A. & Levy, R. (1994) Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood, 84, 2457-2466.
16. McLaughlin, P., Grillo-Lopez, A.J., Link, B.K., Levy, R., Czuczman, M.S., Williams, M.E., Heyman, M.R., Bence-Bruckler, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. & Dallaire, B.K. (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology, 16, 2825-2833.
17. Pilarski, L.M. & Belch, A.R. (1994) Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood, 83, 724-736.
18. Reff, M.E., Carner, K., Chambers, K.S., Chinn, P.C., Leonard, J.E., Raab, R., Newman, R.A., Hanna, N. & Anderson, D.R. (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood, 83, 435-445.
19. Szczepek, A.J., Seeberger, K., Wizniak, J., Mant, M.J., Belch, A.R. & Pilarski, L.M. (1998) A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood, 92, 2844-2855.